In addition, CK18 is not a cancer specific biomarker, which is altered in other diseases, such as liver dysfunction, intracerebral hemorrhage and malignant middle cerebral artery infarction 43-45. This evidence concerns the gene KRT18 and intracerebral hemorrhage.